Table 2.
Analgesics, sedatives, and antipsychotics | Value |
---|---|
PRN medications | |
IV or PO PRN opioids, n (%) | |
Fentanyl | 6 (29) |
Morphine | 4 (19) |
Hydromorphone | 1 (5) |
IV or PO PRN sedatives, n (%) | |
Midazolam | 3 (14) |
Lorazepam | 2 (10) |
Diazepam | 1 (5) |
IV or PO PRN antipsychotics, n (%) | |
Haloperidol | 1 (5) |
Atypical antipsychotics | 1 (5) |
IV or PO PRN medications, none, n (%) | 9 (43) |
| |
ATC medications | |
IV, PO or transdermal ATC opioids, n (%) | |
Methadone | 1 (5) |
IV or PO ATC sedatives, n (%) | |
Lorazepam | 1 (5) |
Clobazam | 1 (5) |
IV or PO ATC medications, none, n (%) | 18 (86) |
| |
Continuous infusions | |
Continuous infusion opioids, n (%) | |
Fentanyl | 10 (48) |
Morphine | 3 (14) |
Hydromorphone | 1 (5) |
Continuous infusion sedatives, n (%) | |
Midazolam | 11 (52) |
Dexmedetomidine | 7 (33) |
Propofol | 3 (14) |
Continuous infusion medications, none, n (%) | 4 (19) |
| |
Adjunctive nonopioid analgesics and sedatives | |
No adjunctive agent, n (%) | 12 (57) |
Acetaminophen, n (%) | 8 (38) |
Lidocaine, n (%) | 1 (5) |
Baclofen, n (%) | 1 (5) |
Clonidine, n (%) | 1 (5) |
IV: intravenous; PO: by mouth; PRN: as needed; ATC: scheduled around the clock.